IBDase
Mucosal protease and their inhibitors in inflammatory bowel disease: From etiopathogenetic insight to innovative therapy
Keystone symposium: Therapeutic Modulation of RNA using Oligonucleotides
February/2009/
Keystone symposium: Therapeutic
Modulation of RNA Using
Oligonucleotides
Fairmont Chateau Lake Louise, Canada
February 8-13, 2009
IBDase contributed with ‘Mucosal proteases and their inhibitors in inflammatory bowel disease: from ethiopathological insight to innovative therapy’.
Fairmont Chateau Lake Louise, Canada
February 8-13, 2009
IBDase contributed with ‘Mucosal proteases and their inhibitors in inflammatory bowel disease: from ethiopathological insight to innovative therapy’.